Core Viewpoint - ST Renfu (600079.SH) announced a stock issuance to its controlling shareholder, China Merchants Biomedical, with the total fundraising amount set between RMB 3 billion and RMB 3.5 billion, aimed at financing various innovative drug research and development projects and other initiatives [1] Group 1: Fundraising Details - The total amount of funds raised will not be less than RMB 3 billion and not exceed RMB 3.5 billion, inclusive of the principal [1] - The funds will be used for several projects, including innovative drug R&D for its subsidiary Yichang Renfu and the headquarters research institute [1] Group 2: Project Allocation - The fundraising will support the construction of a manufacturing base for sexual health and complex formulations [1] - Additional allocations include investments in digital intelligence construction and replenishing working capital [1]
ST人福拟定增募资30亿元至35亿元